Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Optiscan.
RELATED STOCKHEAD STORIES
News
Last Orders: ASX small caps gain over 1 per cent to start the week
Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
News
Last Orders: What you might have missed on the ASX today
News
ASX Small Cap Lunch Wrap: Who’s looking a bit rough around the edges?
News
10 at 10: These ASX stocks are emerging from the earth this morning
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Check Up: A bit of progress for the health sector
Health & Biotech
Check up: COVID-19 still sells but investors are looking for the next endorphin hit
Health & Biotech
Health: Bionomics looks to get ‘back on track’ as it switches into the fast lane for US approval
Health & Biotech
Health: Immutep bounces off decade-long lows thanks to cash from GSK
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
Health & Biotech
Optiscan says it’s business-as-usual despite unrest among rebel shareholders
Health & Biotech
Battle for Optiscan heats up with second bid to overturn the board
Health & Biotech
